Stock Fundamentals

Company Information

Company Name
Rapport Therapeutics, Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US75383L1026
Currency: USD
Full Time Employees: 84
Phone: 857 321 8020
Fiscal Year End: December
IPO Date: Jun 07, 2024
Description:

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company's lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. It also develops nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and migraine; and a9a10 nAChR for the treatment of hearing/vestibular disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.

Address:

99 High Street, Boston, MA, United States, 02110

Directors & Officers

Name Title Year Born
Dr. Steven M. Paul M.D. Founder & Independent Chairman 1951
Mr. Abraham N. Ceesay M.B.A. CEO, President, Treasurer & Director 1978
Mr. Troy A. Ignelzi Chief Financial Officer 1968
Dr. Jeffrey Sevigny M.D. Chief Medical Officer 1970
Dr. David Bredt M.D., Ph.D. Founder & Chief Scientific Officer 1966
Ms. Cheryl Gault Chief Operating Officer 1980
Ms. Karina Chmielewski Chief Information Officer & Head of Operations NA
Ms. Julie DiCarlo Head of Communications & Investor Relations NA
Ms. Kathleen A. Wilkinson Chief People Officer 1972
Mr. Swamy Yeleswaram Ph.D. Chief Development Officer 1964

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 17, 2026 Rock Ventures V L.P. Third N/A Sale 426.01K $40.32 $17.18M
Apr 17, 2026 Krishnaswamy Yeleswaram N/A Sale 20.23K $39.99 $808.80K
Apr 14, 2026 Krishnaswamy Yeleswaram N/A Sale 10.20K $35.08 $357.82K
Apr 13, 2026 Krishnaswamy Yeleswaram N/A Sale 9.17K $34.97 $320.50K
Apr 10, 2026 Krishnaswamy Yeleswaram N/A Sale 500.00 $34.98 $17.49K
Apr 08, 2026 Krishnaswamy Yeleswaram N/A Sale 360.00 $34.90 $12.56K
Mar 05, 2026 Cheryl Gault N/A Sale 2.01K $28.93 $58.27K
Feb 18, 2026 Abraham Ceesay N/A Sale 5.83K $29.34 $171.14K
Feb 18, 2026 Abraham Ceesay N/A Sale 5.08K $29.36 $149.24K
Feb 17, 2026 David Bredt N/A Sale 8.50K $29.02 $246.67K
Jan 20, 2026 Abraham Ceesay N/A Sale 5.83K $26.12 $152.36K
Jan 20, 2026 Abraham Ceesay N/A Sale 5.08K $26.11 $132.72K
Jan 15, 2026 David Bredt N/A Sale 8.50K $26.84 $228.14K
Dec 31, 2025 David Bredt N/A Sale 6.57K $30.05 $197.34K
Dec 31, 2025 Krishnaswamy Yeleswaram N/A Sale 2.84K $30.05 $85.34K
Dec 17, 2025 Abraham Ceesay N/A Sale 5.83K $29.64 $172.89K
Dec 17, 2025 Abraham Ceesay N/A Sale 5.08K $29.63 $150.61K
Dec 15, 2025 David Bredt N/A Sale 8.50K $30.02 $255.17K
Nov 17, 2025 Abraham Ceesay N/A Sale 5.83K $25.19 $146.93K
Nov 17, 2025 Abraham Ceesay N/A Sale 5.08K $25.20 $128.09K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 7.17M Mar 31, 2026 15.00% $0.01 0.80%
TRV GP V, LLC 7.14M Mar 31, 2026 14.92% $55.68 0.00%
ARCH VENTURE CORP 3.73M Mar 31, 2026 7.80% $17.23 0.00%
Capital Research & Mgmt Co - Division 3 3.10M Mar 31, 2026 6.48% $0.02 -8.95%
Cormorant Asset Management, LLC 2.96M Mar 31, 2026 6.19% $4.65 -2.31%
The Goldman Sachs Group Inc 2.94M Mar 31, 2026 6.15% $0.01 -1.99%
BlackRock Inc 2.51M Mar 31, 2026 5.24% $0.00 3.05%
Sofinnova Ventures 1.90M Mar 31, 2026 3.98% $2.26 0.00%
Vanguard Group Inc 1.82M Dec 31, 2025 3.80% $0.00 11.76%
Johnson & Johnson 1.78M Mar 31, 2026 3.73% $8.56 0.00%
Polar Capital Holdings PLC 1.64M Mar 31, 2026 3.44% $0.18 63.47%
Baker Bros Advisors LP 1.55M Mar 31, 2026 3.24% $0.28 0.00%
Vestal Point Capital LP 1.44M Mar 31, 2026 3.00% $1.26 29.39%
TRV GP VI, LLC 969.22K Mar 31, 2026 2.03% $22.37 0.00%
UBS Asset Mgmt Americas Inc 918.87K Mar 31, 2026 1.92% $0.01 -3.52%
T. Rowe Price Associates, Inc. 866.46K Mar 31, 2026 1.81% $0.00 -1.72%
State Street Corp 759.55K Mar 31, 2026 1.59% $0.00 6.26%
AllianceBernstein L.P. 727.84K Mar 31, 2026 1.52% $0.01 -7.68%
Geode Capital Management, LLC 721.62K Mar 31, 2026 1.51% $0.00 3.87%
Perceptive Advisors LLC 673.92K Mar 31, 2026 1.41% $0.41 0.00%

Shares Statistics

Shares Outstanding: 47.83M
Shares Float: 31.75M
% Insiders: 465.40%
% Institutions: 10,947.70%
Short % Float: 8.01%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 American Funds SMALLCAP World A 3.63M 7.60% ▲ 6.82% Mar 31, 2026
2 Fidelity Growth Compy Commingled Pl S 3.17M 6.62% ▲ 11.00% Mar 31, 2026
3 Fidelity Growth Company Fund 2.23M 4.66% ▲ 11.70% Mar 31, 2026
4 Polar Capital Biotech S Inc 1.55M 3.25% ▲ 3.56% Mar 31, 2026
5 Vanguard Total Stock Mkt Idx Inv 973.33K 2.04% ▲ 0.00% Apr 30, 2026
6 iShares Russell 2000 ETF 696.26K 1.46% ▲ 0.85% Apr 30, 2026
7 Fidelity Growth Company K6 687.26K 1.44% ▲ 8.98% Mar 31, 2026
8 T. Rowe Price Health Sciences 636.41K 1.33% ▲ 17.92% Mar 31, 2026
9 Fidelity Series Growth Company 586.41K 1.23% ▲ 11.37% Mar 31, 2026
10 Fidelity Select Biotechnology 471.77K 0.99% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $1.31B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.77B
EBITDA: $-121.21M
Book Value: $9.86
Earnings/Share: $-2.60
Profit Margin: 0.00%
Operating Margin: -121.08%
ROA (TTM): -19.10%
ROE (TTM): -28.33%
Revenue (TTM): $20.00M
Revenue/Share (TTM): $0.48
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 26.17x 0.01x 0.05x N/A -0.02x
2024-12-31 35.34x 0.00x 0.03x N/A -0.01x
2023-12-31 17.14x -0.03x 1.16x N/A -0.02x
2022-12-31 18.80x 0.00x 0.38x -36.38x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RAPP.US!